262 related articles for article (PubMed ID: 32273945)
21. Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma.
Yang Y; Zhang N; Zhu J; Hong XT; Liu H; Ou YR; Su F; Wang R; Li YM; Wu Q
Int J Oncol; 2017 Jun; 50(6):1977-1988. PubMed ID: 28498415
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
[TBL] [Abstract][Full Text] [Related]
24. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
25. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
26. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
27. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
28. The Protein Kinase Activity of NME7 Activates Wnt/β-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma.
Ren X; Rong Z; Liu X; Gao J; Xu X; Zi Y; Mu Y; Guan Y; Cao Z; Zhang Y; Zeng Z; Fan Q; Wang X; Pei Q; Wang X; Xin H; Li Z; Nie Y; Qiu Z; Li N; Sun L; Deng Y
Cancer Res; 2022 Jan; 82(1):60-74. PubMed ID: 34764205
[TBL] [Abstract][Full Text] [Related]
29. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation.
Wu N; Zhang YL; Wang HT; Li DW; Dai HJ; Zhang QQ; Zhang J; Ma Y; Xia Q; Bian JM; Hang HL
Cancer Biol Ther; 2016 May; 17(5):558-65. PubMed ID: 27124543
[TBL] [Abstract][Full Text] [Related]
31. WNT/β-catenin signaling in the development of liver cancers.
He S; Tang S
Biomed Pharmacother; 2020 Dec; 132():110851. PubMed ID: 33080466
[TBL] [Abstract][Full Text] [Related]
32. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
33. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
34. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
[TBL] [Abstract][Full Text] [Related]
35. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
[TBL] [Abstract][Full Text] [Related]
36. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in hepatocellular carcinoma cells.
Fan WH; Du FJ; Liu XJ; Chen N
Oncol Rep; 2016 Nov; 36(5):2999-3004. PubMed ID: 27666874
[TBL] [Abstract][Full Text] [Related]
39. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
40. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
